 FTA-ABS test
Definition Alternative Names How the test is performed How to prepare for the test How the test will feel Why the test is performed Normal Values What abnormal results mean What the risks are Special considerations References DefinitionThe FTA-ABS test is a blood test to detect antibodies to the bacteria Treponema pallidum, which causes syphilis. This test is used to confirm whether a positive screening test for syphilis means there is a true infection. Alternative NamesFluorescent treponemal antibody absorption test How the test is performedBlood is drawn from a vein, usually from the inside of the elbow or the back of the hand. The site is cleaned with germ-killing medicine (antiseptic). The health care provider wraps an elastic band around the upper arm to apply pressure to the area and make the vein swell with blood. Next, the health care provider gently inserts a needle into the vein. The blood collects into an airtight vial or tube attached to the needle. The elastic band is removed from your arm. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding. In infants or young children, a sharp tool called a lancet may be used to puncture the skin and make it bleed. The blood collects into a small glass tube called a pipette, or onto a slide or test strip. A bandage may be placed over the area if there is any bleeding. How to prepare for the testNo special preparation is necessary. How the test will feelWhen the needle is inserted to draw blood, you may feel moderate pain, or only a prick or stinging sensation. Afterward, there may be some throbbing. Why the test is performedThis test is used routinely to confirm whether a positive screening test for syphilis (either VDRL or RPR ) reflects true infection with syphilis. It may also be done when either primary or tertiary syphilis are suspected and the initial screening tests are negative, because screening tests during these stages of syphilis may be falsely negative. Normal ValuesA negative or nonreactive result means there is no current or past infection with syphilis. What abnormal results meanA positive FTA-ABS usually indicates infection with syphilis. This test result will remain positive for life even if syphilis has been adequately treated. Therefore, it cannot be used to monitor the treatment of syphilis. Other illnesses such as yaws and pinta may also result in positive FTA-ABS results. Occasionally there can be a false positive result, most often in women with lupus. What the risks areVeins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others. Other risks associated with having blood drawn are slight but may include: - Excessive bleeding
- Fainting or feeling light-headed
- Hematoma (blood accumulating under the skin)
- Infection (a slight risk any time the skin is broken)
Special considerations  Blood test
ReferencesHook EW III. Syphilis. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 340. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Diseases characterized by genital ulcers. Sexually transmitted diseases treatment guidelines 2006. MMWR Morb Mortal Wkly Rep. 2006 Aug 4;55(RR-11):14-30. Eckert LO, Lentz GM. Infections of the lower genital tract: vulva, vagina, cervix, toxic shock syndrome, HIV infections. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia, Pa: Mosby Elsevier; 2007:chap 22. Physician ReferenceCurrent Procedural Terminology (CPT)86781
Review Date: 7/27/2009
Reviewed By: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; and Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Redmond, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
|